Concentration-effect curves of complexes 1-3 in the human ovarian cancer cell line CH1 Stability and protein binding studies using NMR spectrosopy and MS List of proteins identified by chemical proteomics.
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3 cells per well (for SW480) and 3 × 10 3 cells per well (for A549). After 24 h preincubation of the cells, the test compounds were dissolved in complete medium and then added in aliquots of 100 μL per well.
After continuous exposure for 96 h, solutions of the compounds were replaced with 86 µL RPMI 1640 medium (supplemented with 10% heat-inactivated fetal bovine serum and 2 mM L-glutamine) plus 14 µL
MTT solution in phosphate-buffered saline (5 mg/mL). After incubation for 4 h, the medium/MTT mixtures were removed, and the formazan crystals formed by viable cells were dissolved in 150 μL of
DMSO per well. Optical densities at 550 nm were measured with a microplate reader (ELx808
Absorbance Microplate Reader, Bio-Tek, USA), using a reference wavelength of 690 nm to correct for unspecific absorption. The quantity of viable cells was expressed in terms of T/C values by comparison to untreated control microcultures, and 50% inhibitory concentrations (IC 50 ) were calculated from concentration-effect curves by interpolation. Evaluation is based on means from at least three independent experiments, each comprising three replicates per concentration level.
Stability Studies. Stability studies for 1 were performed on an AmaZon SL ion trap mass spectrometer using ESI Compass 1.3 software (Bruker Daltonics GmbH, Bremen, Germany). The samples were introduced by direct infusion at a flow rate of 180 µL/h. Compound 1 was dissolved in dimethylsulfoxide or dry N,N-dimethylformamide, respectively, and was incubated for the appropriate time. The sample was diluted with water : methanol (1 : 1) to a final concentration of 5 µM prior to injection into the instrument. Typical instrument parameters were as follows: average accumulation time ~1500 µs, dry gas 6.0 L/min, dry temperature 100 °C, end plate offset -500 V, HV capillary -3.5 kV, nebulizer 8 psi, RF Level 63%, trap drive 55.2. The Data Analysis 4.0 software package (Bruker Daltonics GmbH, Bremen, Germany) was used for processing of the raw data. Stability studies in aqueous solution were carried out as described below.
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Protein Binding Studies. Compounds 1 or 3 (400 µM) and ubiquitin or cytochrome-c (400 µM) were dissolved in water and tetramethylammonium acetate (20 mM). These stock solutions were mixed to obtain a 2 : 1 metal-to-ubiquitin and a 3 : 1 metal-to-cytochrome-c molar ratio. Docking Experiments. The structures were docked to a streptavidin crystal structure (3RY2, resolution 0.95 Å), 7 which was obtained from the Protein Data Bank (PDB). 8, 9 The Scigress Ultraversion 7.7.0.47 program 10 was used to prepare the crystal structure for docking, i.e. hydrogen atoms were added, the cocrystallized ligand (biotin) was removed as well as crystallographic water molecules. The Scigress software suite was also used to build the compounds and the MM2 11 force field was used to optimize the structures. The center of the binding pocket was defined as the oxygen atom on the bicyclic system (x = 27.048, y = 10.773, z = 12.293) in biotin with 10 Å radius. Fifty docking runs were allowed for each ligand with default search efficiency (100%). The basic amino acids lysine and arginine were defined as protonated. Furthermore, aspartic and glutamic acids were assumed to be deprotonated. All the bonds to the metal centre were fixed for the docking runs. The GoldScore (GS), 12 ChemScore (CS), 13, 14 ChemPLP 15 and ASP 16 algorithms in the GOLD v5.1 software suite were implemented to predict binding modes and relative energies of the ligands.
Drug Pull-Down. For preparation of cell lysates, CH1 cells (see above) were lysed with lysis buffer (50 mM Tris-HCl, 100 mM NaCl, 0.2% NP-40, 5% glycerol, 1.5 mM MgCl 2 , 25 mM NaF, 1 mM Na 3 VO 4 , 1 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol (DTT), 10 μg/mL TLCK, 1 μg/mL leupeptin, 1 μ g/mL aprotinin, and 10 μg/mL soybean trypsin inhibitor (Sigma), pH 7.5). Per pull-down experiment,
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was distributed in Eppendorf tubes, centrifuged, and the supernatant removed. After washing with lysis buffer (3 × 1 mL), 50 mmol of biotin-conjugated compound 3 was added (prepared as described below) and incubated on a roto-shaker for 30 min at 4 °C. After centrifugation and one additional washing step, the beads were resuspended in CH1 lysates (10 mg per pull-down) and incubated on a roto-shaker for 2 h at 4 °C. For competition experiments, lysates were preincubated with 20 µM of 2 for 20 min at 4 °C.
After centrifugation, beads were transferred to spin columns (MoBiTec) and washed with lysis buffer (5 mL) and HEPES (2.5 mL), respectively. To elute bound proteins, the beads were treated with 250 µL elution buffer (3 M urea, 50 mM formic acid) and the eluates were collected in glass vials.
Liquid chromatography-mass spectrometry. Mass spectrometry was performed on a hybrid LTQ Orbitrap Velos mass spectrometer (ThermoFisher Scientific, Waltham, MA, USA) using Xcalibur version Maisch GmbH, Ammerbuch-Entringen, Germany). The peptides were eluted from the analytical column with a 27 min gradient ranging from 3 to 30% solvent B, followed by a 25 min gradient from 30 to 70% solvent B and, finally, a 7 min gradient from 70 to 100% solvent B at a constant flow rate of 100 nL/min. 17 The analyses were performed in a data-dependent acquisition mode and dynamic exclusion for selected ions was 60 s. A top 15 collision-induced dissociation (CID) method was used, and a single lock mass at m/z 445.120024 (Si(CH 3 ) 2 O) 6 ) was employed. 18, 19 Maximal ion accumulation time allowed in CID mode was 50 ms for MS n in the LTQ and 500 ms in the C-trap. Automatic gain control was used to prevent overfilling of the ion traps and was set to 5000 in MSn mode for the LTQ and 10 6 ions for a full FTMS scan. Intact peptides were detected in the Orbitrap Velos at 60000 resolution at m/z 400. All samples were analyzed as biochemical and technical duplicates.
Data analysis.
The acquired raw MS data files were processed with msconvert (ProteoWizard Library v2.1.2708) and converted into Mascot generic format (mgf) files. The resultant peak lists were searched against the human SwissProt database version v2012.05_20120529 (36898 sequences, respectively, including isoforms, as obtained from varsplic.pl) with the search engines Mascot (v2.3.02, MatrixScience, London, UK) and Phenyx (v2.5.14, GeneBio, Geneva, Switzerland). 19 Submission to the search engines S6 was via a Perl script that performs an initial search with relatively broad mass tolerances (Mascot only) on both the precursor and fragment ions (±10 ppm and ±0.6 Da, respectively). High-confidence peptide identifications were used to recalibrate all precursor and fragment ion masses prior to a second search with narrower mass tolerances (±4 ppm and ±0.3 Da). One missed tryptic cleavage site was allowed.
Carbamidomethyl cysteine was set as a fixed modification and oxidized methionine was set as a variable modification. To validate the proteins, Mascot and Phenyx output files were processed by internallydeveloped parsers. Proteins with ≥2 unique peptides above a threshold score T1, or with a single peptide above a score T2 were selected as unambiguous identifications. Additional peptides for these validated proteins with score >T3 were also accepted. For Mascot and Phenyx, T1, T2 and T3 peptide scores were equal to 16, 40, 10 and 5.5, 9.5, 3.5, respectively (P-value <0.001). The validated proteins retrieved by the two algorithms were merged, any spectral conflicts discarded and grouped according to shared peptides.
A false positive detection rate (FDR) of <1% and <0.1% (including the peptides exported with lower scores) was determined for proteins and peptides, respectively, by applying the same procedure against a reversed database. , where n is the number of reflections and p is the total number of parameters refined. b data for one of two independent molecules is given.
Synthesis of N-(cyclohexa-1,4-dienylmethyl)acetamide (c
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Figure S1
. Docked configurations of ruthenium derivative 2 in the binding site of streptavidin for the three highest scoring GS runs overlaid. The biotin moiety shows good overlap with biotin observed in the crystal structure of the conjugate and the RAPTA part is flexible and accessible at the protein surface. 
